...
首页> 外文期刊>Ophthalmology >Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival.
【24h】

Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival.

机译:Descemet的膜内皮角膜移植术:关于视觉和屈光结局以及内皮生存的前瞻性多中心研究。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To describe Descemet's membrane endothelial keratoplasty (DMEK) techniques, perioperative challenges, management, and visual and refractive outcomes. DESIGN: Prospective, multicenter, consecutive case series. PARTICIPANTS: Sixty eyes of 56 patients with Fuchs' endothelial dystrophy, pseudophakic bullous keratopathy, or failed previous graft. INTERVENTION: Descemet's membrane (DM) and endothelium were stripped from donor corneas submerged in corneal storage solution in a corneal viewing chamber. Donor DM diameters were 8.5 or 9.0 mm. The central 7 mm of DM was stripped from the recipient cornea. After staining with trypan blue to improve visualization, donor DM was inserted through a 2.8-mm incision. Descemet's membrane endothelial keratoplasty was performed alone (n = 48) or was combined with phacoemulsification and lens implantation (n = 11), pars plana vitrectomy (n = 2), or both. MAIN OUTCOME MEASURES: Best spectacle-corrected visual acuity (BSCVA), manifest refraction, and endothelial cell density. RESULTS: Median BSCVA was 20/30 at 1 month (range, 20/20-20/60), improving from 20/50 (range, 20/25-hand movements) before DMEK, excluding 4 eyes (7%) with preexisting ocular pathologic features that limited visual potential. At 3 months, 26% had 20/20 vision, 63% saw 20/25 or better, and 94% saw 20/40 or better. Refractive cylinder remained unchanged at 0.9 diopters (D; P = 0.93), and a hyperopic shift of 0.49+/-0.63 D (P = 0.0091) was noted in DMEK single procedures. Endothelial cell loss was 30%+/-20% at 3 months and 32%+/-20% in 38 eyes that reached the 6-month examination. Median pachymetry decreased from 660 mum before surgery to 530 mum. Descemet's membrane stripped successfully from 60 of 72 donor corneas; 6 were converted successfully to Descemet's stripping automated endothelial keratoplasty (DSAEK) and 6 (8%) were discarded. Only 1 graft detached completely, but air was reinjected in 38 eyes (63%), mainly for partial detachments. Five DMEK corneas (8%) failed to clear and were replaced successfully with DMEK or DSAEK. All remained clear at last follow-up. CONCLUSIONS: Compared with DSAEK, DMEK provided a significantly higher rate of 20/20 and 20/25 vision, with comparable endothelial cell loss. Descemet's membrane endothelial keratoplasty restored physiologic pachymetry, but donor preparation and attachment currently are more challenging than with DSAEK.
机译:目的:描述Descemet的膜内皮角膜移植术(DMEK)技术,围手术期的挑战,管理以及视觉和屈光结果。设计:前瞻性,多中心,连续案例系列。参与者:56例Fuchs内皮营养不良,假晶状体大疱性角膜病或先前移植失败的患者的60只眼。干预:从浸没在角膜观察室内的角膜储存溶液中的供体角膜上剥去Descemet膜(DM)和内皮。供体DM的直径为8.5或9.0mm。从受体角膜剥离中心的7mm DM。用台盼蓝染色以改善可视化效果后,将供体DM通过2.8毫米切口插入。 Descemet的膜内皮角膜移植术是单独进行的(n = 48),或与超声乳化和晶状体植入术(n = 11),平面玻璃体切除术(n = 2)或两者结合进行。主要观察指标:最佳眼镜矫正视力(BSCVA),明显屈光和内皮细胞密度。结果:在1个月(范围为20 / 20-20 / 60)的BSCVA中位数为20/30,较DMEK之前的20/50(范围为20/25的手部动作)有所改善,排除了4眼(7%)既往存在限制视力的眼部病理特征。在3个月时,有26%的人视力为20 / 20,63%的人视力为20/25或更高,有94%的人视力为20/40或更高。屈光度数保持不变,为0.9屈光度(D; P = 0.93),在DMEK单次手术中,屈光度为0.49 +/- 0.63 D(P = 0.0091)。 3个月时内皮细胞损失为30%+ /-20%,到达6个月检查的38只眼中内皮细胞损失为32%+ /-20%。中位测厚术从术前的660毫米降低到530毫米。 Descemet的膜成功地从72个供体角膜中剥离了60个;成功地将6例转化为Descemet的剥离自动角膜内皮成形术(DSAEK),并丢弃了6例(8%)。只有1个移植物完全脱离,但38眼(63%)再次注入了空气,主要是部分脱离。五个DMEK角膜(8%)未能清除,并成功地被DMEK或DSAEK取代。在上一次随访中,所有患者均保持清晰。结论:与DSAEK相比,DMEK提供了更高的20/20和20/25视力率,并且内皮细胞损失相当。 Descemet的膜内皮角膜移植术恢复了生理测厚法,但与DSAEK相比,目前的供体准备和附着更具挑战性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号